Article Versions Notes

Speranza D, Omero F, Cianci V, Marafioti M, Infurna C, Carroccio P, Spina E, Barbieri MA, Esposito E, Silvestris N, et al. Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance. Pharmaceuticals. 2025; 18(4):528. https://doi.org/10.3390/ph18040528

Speranza, Desirèe, Fausto Omero, Vincenzo Cianci, Mariapia Marafioti, Carla Infurna, Patrizia Carroccio, Edoardo Spina, Maria Antonietta Barbieri, Emanuela Esposito, Nicola Silvestris, and et al. 2025. "Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance" Pharmaceuticals 18, no. 4: 528. https://doi.org/10.3390/ph18040528

Speranza, D., Omero, F., Cianci, V., Marafioti, M., Infurna, C., Carroccio, P., Spina, E., Barbieri, M. A., Esposito, E., Silvestris, N., & Santarpia, M. (2025). Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance. Pharmaceuticals, 18(4), 528. https://doi.org/10.3390/ph18040528